825
A clinically atypical, neuropathologically verified case of Creutzfeldt-Jakob disease is described in a 32-year-old New Zealand woman with idiopathic hypopituitarism who had been treated in late adolescence (1970 to 1973) with human growth hormone processed from pooled cadaveric pituitary glands.
 a 32-year-old New Zealand woman with idiopathic hypopituitarism: Subject; 32-year-old: Subject.Age; New Zealand: Subject.Race; woman: Subject.Gender; Creutzfeldt-Jakob disease: Effect; human growth hormone: Treatment; idiopathic hypopituitarism: Treatment.Disorder; human growth hormone: Treatment.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a 32-year-old New Zealand woman with idiopathic hypopituitarism: Subject; 32-year-old: Subject.Age; New Zealand: Subject.Race; woman: Subject.Gender; Creutzfeldt-Jakob disease: Effect; human growth hormone: Treatment; idiopathic hypopituitarism: Treatment.Disorder; human growth hormone: Treatment.Drug